Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer

NCT07085182 is registered in ClinicalTrials.gov with Zibo Municipal Hospital as lead sponsor.

NCT NCT07085182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07085182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer
Lead sponsor
Zibo Municipal Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
January 13, 2024
Completion date
December 10, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy, hypofractionated radiotherapy, nsclc, tislelizumab